SOPH (Sophia Genetics) EPS (Diluted): $-1.18 (TTM As of Mar. 2026)

What is Sophia Genetics EPS (Diluted)?

Sophia Genetics SOPH -4.12% 73 EPS (Diluted) is $-1.18 as of Mar. 2026. GuruFocus rates SOPH with a GF Score™ of 73/100 and a GF Value™ of $5.04 (Fairly Valued). The stock has 6 warning signs investors should review.

Sophia Genetics's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was $-0.27. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.18.

Sophia Genetics's EPS (Basic) for the three months ended in Mar. 2026 was $-0.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.18.

Sophia Genetics's EPS without NRI for the three months ended in Mar. 2026 was $-0.27. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.14.

During the past 3 years, the average EPS without NRIGrowth Rate was 5.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Sophia Genetics's highest 3-Year average EPS without NRI Growth Rate was 8.80% per year. The lowest was -24.70% per year. And the median was -4.20% per year.

Sophia Genetics (NAS:SOPH) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sophia Genetics EPS (Diluted) Related Terms

Sophia Genetics EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Sophia Genetics's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sophia Genetics EPS (Diluted) Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Diluted)

Get a 7-Day Free Trial

-1.33

-1.36

-1.22

-0.95

-1.17

Sophia Genetics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Diluted)	Get a 7-Day Free Trial															-0.26	-0.33	-0.30	-0.28	-0.27

SOPH vs WEAV, NRC, MDRX: EPS (Diluted) Comparison

For the Health Information Services subindustry, Sophia Genetics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sophia Genetics PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's PE Ratio falls into.

Save Embed

73GF Score

Sophia Genetics SA SOPH

EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sophia Genetics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Sophia Genetics's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-78.999	-	0)	/	67.540
	=	-1.17

Sophia Genetics's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-19.322	-	0)	/	71.138
	=	-0.27

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.18

Frequently Asked Questions Learn more about EPS (Diluted) →

What does a EPS (Diluted) of $-1.18 mean?

Sophia Genetics (SOPH) has a EPS (Diluted) of $-1.18 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Sophia Genetics and its competitors.

Is Sophia Genetics' EPS (Diluted) too high?

Sophia Genetics' current EPS (Diluted) is $-1.18. Overall, Sophia Genetics has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Sophia Genetics' EPS (Diluted) compare to WEAV and NRC?

Sophia Genetics' EPS (Diluted) of $-1.18 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Diluted) for a Healthcare Providers & Services company?

A good EPS (Diluted) depends on the Healthcare Providers & Services industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Diluted) mean?

A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Sophia Genetics and its competitors. Sophia Genetics's current EPS (Diluted) is $-1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sophia Genetics stock overvalued right now?

Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Fairly Valued. The stock's GF Value™ is $5.04, compared to a current price of $5.36 — trading 6.3% above its estimated fair value. The current EPS (Diluted) is $-1.18. Sophia Genetics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Diluted) calculated?

EPS (Diluted) is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current EPS (Diluted) is $-1.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.36 is trading 6.3% above its estimated GF Value™ of $5.04. GuruFocus considers Sophia Genetics to be Fairly Valued.

Key valuation signals for SOPH:

EPS (Diluted): $-1.18
GF Value™: $5.04 vs. price of $5.36 (6.3% above fair value)
GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies WEAV NRC MDRX CTEV TBRG SLP EVH PHR CARL SPOK VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY

Other Exchanges 90B:Germany

Address La Piece 12, Rolle, CHE, CH-1180

Website https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

73GF Score

Get the complete analysis for SOPH

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.36

Price

$5.04

GF Value

View SOPH Analysis

See EPS (Diluted) data for all stocks →